Dr Richard Beckman, a board-certified ophthalmologist and fellowship trained glaucoma specialist, has over 30 years of experience in the pharmaceutical/medical device industry and has spent over 20 years developing innovative therapies for diseases of the eye.
Dr Beckman was the Chief Medical Officer of several innovative biotech and device firms, including Adverum, ReNeuron, Clearside, Unilife, Ophthotech and Neurotech. Prior to that, he had leadership roles at Alcon, where he was the head of glaucoma development for both pharma and medical devices, Lux Bio, Becton Dickinson and Allergan.
Dr Beckman received his MD from the University of Michigan, completed a residency in ophthalmology at Henry Ford Hospital, and a glaucoma fellowship at the Mass. Eye and Ear Infirmary/Harvard University. Prior to joining the industry, he practiced in academic medicine for three years at Cornell University Medical College and was in private practice for 10 years.
